300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
Oil and Gas
InsurTech
Cryptocurrency
Retail
Social Impact
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Renewable Energy
Software
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Music
Food and Beverage
Publishing
Manufacturing
Digital Media
FinTech
Art
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Real Estate
Non Profit
Internet
Sporting Goods
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Burkina Faso
Oman
Romania
Puerto Rico
Poland
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Malta
Luxembourg
Mozambique
Namibia
Mauritius
Panama
Nicaragua
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Morocco
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Seychelles
Moldova
Botswana
Ireland
Paraguay
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Canada
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
United Kingdom
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Argentina
Cyprus
Qatar
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Bangladesh
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Life Science Angel Investors (August 2026)

The most active angel investors investing in Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Life Science startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Jonathan Milner
Angel
12 United Kingdom, United States, Spain Seed, Series A, Series B Biotechnology, Health Care, Medical $537k–$56M
Sahin Boydas
Angel
9 United States, Mexico, Norway Seed, Series A, Series B Software, Financial Services, Information Technology $500k–$150M
Milad Alucozai
Angel
7 United States, Canada, United Kingdom Seed, Series A, Pre-Seed Biotechnology, Health Care, Artificial Intelligence $110k–$60M
Nadav Rosenberg
Angel
5 United Kingdom, France, Israel Seed, Pre-Seed, Series A Software, Biotechnology, Artificial Intelligence $850k–$21M
Jeff Dean
Angel
5 United States, United Kingdom, Japan Seed, Series A, Pre-Seed Artificial Intelligence, Information Technology, Software $450k–$60M
Balaji Srinivasan
Angel
4 United States, India, Singapore Seed, Pre-Seed, Series A Blockchain, Cryptocurrency, Software $450k–$28M
Sam Altman
Angel
4 United States, Canada, Ghana Seed, Series A, Series B Software, Artificial Intelligence, Biotechnology $1.2M–$100M
Jude Gomila
Angel
4 United States, United Kingdom, India Seed, Pre-Seed, Angel Software, Information Technology, Biotechnology $70k–$5M
Kevin Moore
Angel
4 United States, India, Canada Seed, Pre-Seed, Angel Software, Health Care, E-Commerce $190k–$5.2M
Edward Lando
Angel
4 United States, United Kingdom, France Seed, Pre-Seed, Series A Software, Artificial Intelligence, FinTech $125k–$37M
bumpkins profile
Angel
4 United States, Canada, India Seed, Series A, Pre-Seed Health Care, Biotechnology, Medical $500k–$57M
Christopher Gibson
Angel
4 United States, United Kingdom, France Series A, Seed, Series B Biotechnology, Health Care, Pharmaceutical $5.4M–$55M
Darian Shirazi
Angel
3 United States, Germany, Canada Seed, Series A, Series B Software, Information Technology, Artificial Intelligence $2M–$73M
Esther Dyson
Angel
3 United States, Canada, Russian Federation Seed, Series A Health Care, Software, Medical $270k–$16M
Bradley Horowitz
Angel
3 United States, United Kingdom, Germany Seed, Series A, Series B Software, Information Technology, Artificial Intelligence $150k–$120M
Chris Gibson
Angel
3 United States, France, Switzerland Series A, Seed Biotechnology, Health Care, Life Science $4.9M–$55M
Ian Hogarth
Angel
3 United Kingdom, United States, Germany Seed, Series A, Pre-Seed Software, Artificial Intelligence, E-Commerce $668k–$28M
Andrew Nutter
Angel
3 France, United Kingdom, United States Seed, Pre-Seed, Series A Software, SaaS, FinTech $550k–$4.9M
Albert Wenger
Angel
3 United States, Germany, Switzerland Series A, Series B, Seed Software, Internet, Analytics $650k–$40M
Erik Peterson
Angel
3 United States, Canada, Algeria Seed, Equity Crowdfunding, Series A Software, SaaS, Mobile $69k–$20M
Mei Z.
Angel
3 United States, United Kingdom, Singapore Seed, Pre-Seed, Series A Artificial Intelligence, Software, Information Technology $1M–$156M
Kevin Mahaffey
Angel
3 United States, Canada, Israel Seed, Series A, Pre-Seed Software, SaaS, Artificial Intelligence $1.3M–$30M
Andrew Keys
Angel
3 United States, India, Norway Seed, Pre-Seed, Series A Software, Finance, Blockchain $1M–$34M
Jeff Hammerbacher
Angel
3 United States, Germany Seed, Series A, Angel Artificial Intelligence, Software, Biotechnology $330k–$25M
Stefano Bernardi
Angel
3 Italy, United Kingdom, France Seed, Pre-Seed Software, Blockchain, Biotechnology $100k–$45M
Zach Weinberg
Angel
2 United States, Israel, United Kingdom Seed, Series A, Pre-Seed Software, Health Care, Medical $1.4M–$30M
David Helgason
Angel
2 United States, Denmark, Finland Seed, Series A, Pre-Seed Software, Gaming, Artificial Intelligence $242k–$30M
CJ Reim
Angel
2 United States Series A, Seed, Series D SaaS, Robotics, E-Commerce $3.7M–$150M
Katie Haun
Angel
2 United States, United Kingdom Seed, Series A Blockchain, Financial Services, FinTech $4.5M–$200M
Carsten Maschmeyer
Angel
2 Germany, Austria, Switzerland Seed, Angel, Series A Software, Artificial Intelligence, Information Technology $89k–$24M
Sujay Jaswa
Angel
2 United States, Spain, Germany Seed, Series B, Series A Software, Apps, FinTech $1.8M–$200M
Lars Fjeldsoe-Nielsen
Angel
2 United States, United Kingdom, Denmark Seed, Series A, Series B Software, Artificial Intelligence, Information Technology $1.8M–$125M
Jon Oringer
Angel
2 United States, France, United Kingdom Seed, Pre-Seed, Series A Software, Information Technology, Health Care $175k–$56M
Ed Parkinson
Angel
2 United Kingdom Seed Health Care, Life Science, Biotechnology $1.9M–$3M
Elad Gil
Angel
2 United States, United Kingdom, Israel Seed, Series A, Series B Software, Information Technology, Artificial Intelligence $2M–$117M
Robert Kopple
Angel
2 United States, United Kingdom Convertible Note, Venture - Series Unknown FinTech, Finance, Life Science $3.3M–$4.8M
James Hong
Angel
2 United States Seed, Series A, Angel E-Commerce, Mobile, Internet $100k–$25M
Avichal Garg
Angel
2 United States, Canada, Mexico Seed, Series A Software, Blockchain, Internet
Jan Hammer
Angel
2 China, United States, Czech Republic Series A, Series B, Seed Health Care, Medical, Medical Device
Michael Novogratz
Angel
2 United States, India, Germany Seed, Series A, Series B Blockchain, FinTech, Cryptocurrency $1.1M–$150M
Nicholas Edwards
Angel
2 United Kingdom Seed Medical, Health Care, Life Science
Annie Vereecken
Angel
2 Belgium Seed, Series A Biotechnology, Medical, Hospital
Luc Vauterin
Angel
2 Belgium Seed, Series A Life Science, Data Integration, Data Visualization
Sauli Törmälä
Angel
2 Finland Seed Life Science, Biotechnology $584k–$1.3M
Pierre Drion
Angel
2 Belgium Series A, Series B Biotechnology, Health Care, Life Science
Holger Hübner
Angel
2 Germany Seed, Pre-Seed B2B, SaaS, Audio $177k–$987k
Peter Harris
Angel
2 United States Seed Life Science, Biotechnology, Health Diagnostics $2.4M–$5M
Leena Niemistö
Angel
2 Finland, United States Seed, Pre-Seed Health Care, Software, E-Commerce $480k–$3.2M
Thor Bjorgolfsson
Angel
2 United Kingdom, Germany Seed, Series A, Series C Big Data, TV, TV Production
Patrick Collison
Angel
2 United States, United Kingdom, Ireland Series A, Seed, Series C Software, Artificial Intelligence, Information Technology $2.7M–$170M
Access all 727 angel investors in Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Jonathan Milner
Angel · Cambridge, Massachusetts, United States · 12 investments in Life Science startups

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Spain

Investor stats

  • Total investments: 62
  • Round size: Seed $537k–$25M; Series A $4.1M–$50M; Series B $1.6M–$56M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 230+ centers worldwide.
  • Nuclera — Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers. Nuclera's eProtein DiscoveryTM system allows scientists to rapidly produce and test proteins for drug discovery.
  • 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
Show all investments...

Sahin Boydas
Angel · San Francisco Bay Area, California, United States · 9 investments in Life Science startups

Sahin Boydas is the PEF Chapter Lead of PEF Community. He previously worked at RemoteTeam.com as CEO and Founder. Sahin Boydas attended Koç University, where he took a Bachelor of Science in Computer Engineering, and Bahcesehir University, where he took a Master of Business Administration in Entrepreneurship.

Show more...

Investment focus

  • Industry: Software, Financial Services, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: United States, Mexico, Norway

Investor stats

  • Total investments: 276
  • Round size: Seed $500k–$15M; Series A $7M–$36M; Series B $23M–$150M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Seezo — Security design reviews for every feature your company builds. Someday, we will be more active on Twitter
  • Neurable — Neurable is a neurotechnology company specializing in developing AI-powered tools for brain signal translation and brain-computer interface technology. Utilizing patented signal processing, developed through research across labs and institutions, and advanced by a scientific and expert product team, its platform enables high-performancebrain-computer interface in everyday devices.
  • Normal Computing — Normal Computing was founded by former members of the Google Brain Team, Palantir, and X who unlocked AI for some of the largest-scale and most mission-critical production systems, and the industry leading ML frameworks for Probabilistic and Quantum AI.
Show all investments...

Milad Alucozai
Angel · San Francisco, California, United States · 7 investments in Life Science startups

Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has experience translating exceptional science and technology into scalable commercial ventures. Alongside his experience as a founder and operator, he has actively invested in over 100 startups across North America and Europe. He has often been thefirst investor to back high-growth companies like Seqera Labs. Milad began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.Milad is a co-founder and General Partner at Pamir Ventures, an early-stage venture firm that invests in technical pioneers developing B2B companies utilizing AI in antiquated industries. He is also a co-founder of Revalia Bio, which aims to establish a human-centric infrastructure for drug discovery and development. By using non-transplantable human organs donated for research, Revalia offers the scientific community unparalleled insights into patient biology, ultimately aiding in the creation of improved treatments and cures. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. His previous roles include supporting business development at Accenture, Absci, Bit Bio, Numerate, Mekonos, and AstraZeneca. Through Digitalis Commons, he was an Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where he aided the US government and ARPA-H mission to enable transformative biomedical and health breakthroughs, providing health solutions through $1.5 billion in non-dilutive investments. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a Visiting Scholar appointment at the Wyss Institute at Harvard University.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Artificial Intelligence
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 55
  • Round size: Seed $1M–$7M; Pre-Seed $110k–$5M; Series A $13M–$60M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Replit — Replit is a simple yet powerful online IDE, Editor, Compiler, Interpreter, and REPL. Code, compile, run, and host in 50+ programming languages.
  • Revalia Bio — Revalia Bio develops curative drugs for chronic organ-centered disease.
  • Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
Show all investments...

Nadav Rosenberg
Angel · London, England, United Kingdom · 5 investments in Life Science startups

Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, France, Israel

Investor stats

  • Total investments: 15
  • Round size: Seed $850k–$3.1M; Pre-Seed $2M–$2M; Series A $18M–$21M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Teora — Crude oil derived products have infiltrated every industry – synthetic colors, flavors, fragrances in food, dyes in textiles, fertilizers and packaging material that harm humans and the planet. TeOra’s mission is to replace synthetics with naturals that are manufactured in a sustainable and predictable manner. A microorganism is the best factory,optimized over billions of years of evolution and TeOra designs it to produce desired products. Using microfluidics and AI, TeOra offers 100 times faster and cheaper design of smart micro-organisms in weeks to months instead of years.
  • thymia — We use video games based on Neuropsychology alongside analyses of video and speech to make mental health assessments smart, starting with depression.Our online platform empowers clinicians so they can assess depression faster, more accurately and objectively. Our multi-modal depression recognition and tracking system allows us to find the righttreatment in weeks instead of years and we make the entire process enjoyable for the patient.
  • Lindus — Lindus Health. From recruitment to delivery, we accelerate clinical trials. Our mission is to make health research accessible for everyone, everywhere.
Show all investments...

Jeff Dean
Angel · Palo Alto, California, United States · 5 investments in Life Science startups

Jeff Dean is the Chief Scientist of Google DeepMind and Google Research. He joined Google in 1999 and has played a pivotal role in shaping the company’s technical foundations. He currently focuses on advancing AI and deep learning research across Google’s research teams.He co-founded and led the Google Brain team, helping drive innovations indeep learning for speech recognition, computer vision, natural language understanding, and a wide range of predictive applications. Over the years, he has co-designed and implemented several generations of Google's core systems, including its web search infrastructure, crawling and indexing pipelines, and advertising technologies such as AdSense for Content.He is also a key contributor to Google's distributed computing infrastructure, having co-designed and implemented systems like MapReduce, BigTable, Spanner, Protocol Buffers, LevelDB, and TensorFlow—one of the most widely used open-source machine learning platforms.Jeff Dean earned his Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the ACM-Infosys Foundation Award in the Computing Sciences and the Mark Weiser Award.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Information Technology, Software
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, Japan

Investor stats

  • Total investments: 104
  • Round size: Seed $2.5M–$35M; Pre-Seed $450k–$2.3M; Series A $10M–$60M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Moonlake AI — Vibe code games and worlds into existence.
  • Belfort — Enabling Fully Homomorphic Encryption through Hardware Acceleration
  • Periodic Labs — From bits to atoms.
Show all investments...

Balaji Srinivasan
Angel · San Francisco Bay Area, California, United States · 4 investments in Life Science startups, 20 in the past 12 months

Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including anonline MOOC.

Show more...

Investment focus

  • Industry: Blockchain, Cryptocurrency, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, India, Singapore

Investor stats

  • Total investments: 271
  • Round size: Seed $2.3M–$15M; Pre-Seed $450k–$4.2M; Series A $6M–$28M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Vorflux — Cloud agents that ship production code. An opinionated harness that runs the full SDLC on dedicated machines.
  • BizScout — BizScout is an online platform of Off market deals for verified buyers and sellers.
  • Warp — Warp is a payroll and compliance tool that makes it easy for founders to hire, onboard, and pay their employees.
Show all investments...

Sam Altman
Angel · San Francisco, California, United States · 4 investments in Life Science startups

Sam Altman is the CEO and co-founder of OpenAI. He is a Partner of Apollo Projects. Altman was the president of Y Combinator. Sam attended Stanford University.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada, Ghana

Investor stats

  • Total investments: 186
  • Round size: Seed $1.2M–$10M; Series A $10M–$50M; Series B $17M–$100M
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • Exowatt — Modular full-stack renewable energy solutions for commercial and industrial customers.
  • Preventive — Preventive mission is to determine whether the newest generation of gene editing technologies can be used safely and responsibly to correct devastating genetic conditions for future children.
  • Red Queen Bio — Red Queen Bio is an AI biosecurity company. Think of us as the cybersecurity layer for biology. AI is making it dramatically easier to design powerful new drugs and therapies, which is extraordinary news for medicine. But the same tools are also lowering the barrier for bad actors to engineer dangerous pathogens, and opening up an entirely new category of threats, including viruses designed to evade human immunity.Defense has to keep pace with offense.
Show all investments...

Jude Gomila
Angel · San Francisco, California, United States · 4 investments in Life Science startups

Jude Gomila is currently CEO and Founder of the startup Golden.

Show more...

Investment focus

  • Industry: Software, Information Technology, Biotechnology
  • Stage:Seed, Pre-Seed, Angel
  • Geography: United States, United Kingdom, India

Investor stats

  • Total investments: 64
  • Round size: Seed $1.4M–$5M; Angel $70k–$1.3M; Pre-Seed $660k–$2.9M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Vaire — Conventional chips waste all their energy as heat. Vaire's groundbreaking technology will recover and recycle most of its energy, delivering low energy, high performance compute for the AI era.
  • Clara — Clara is an AI-powered primary care doctor.
  • Farmako — Install Farmako app, get a free health ID and get all your medical records safe and secure in one place!
Show all investments...

Kevin Moore
Angel · Dallas, Texas, United States · 4 investments in Life Science startups

Kevin Moore has 10 years experience as an angel/opportunity investor and operator. Prior to that, he has over 15 years of progressive technology i-banking, corp dev, and CFO experience at startups and $Bn corporates.

Show more...

Investment focus

  • Industry: Software, Health Care, E-Commerce
  • Stage:Seed, Pre-Seed, Angel
  • Geography: United States, India, Canada

Investor stats

  • Total investments: 101
  • Round size: Seed $190k–$5.2M; Pre-Seed $800k–$2.7M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • SilkChart — SilkChart helps growth teams improve campaigns based on what users are doing in product - without relying on expensive data scientists. We do this through a no code analytics tool that combines marketing and product usage data to identify which channels, audiences, and content maximize revenue growth.
  • Trace — Trace is an orchestration engine that breaks down existing workflows, assigns repetitive tasks to AI agents and routes the rest to the right people.
  • Augmend — Create documentation and an AI assistant from any video.
Show all investments...

Edward Lando
Angel · San Francisco, California, United States · 4 investments in Life Science startups

Edward Lando is the founder of Pareto Holdings. He previously worked at Horizons School of Technology as a co-founder. Edward Lando attended the Wharton School.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, FinTech
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 478
  • Round size: Seed $975k–$7M; Pre-Seed $125k–$3.4M; Series A $5.5M–$37M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • Humera — Humera - AI CAPTCHA That Knows You're Human
  • Allonic — Allonic is a robotics hardware company pioneering 3D Tissue Braiding, a new manufacturing platform for producing integrated, compliant, bio-inspired robotic bodies through a single, fully automated production process. By eliminating assembly-heavy designs and supply-chain complexity, Allonic enables significantly faster iteration, lower costs, andsafer, more dexterous robots to be built. Originally founded from Hungary and operating internationally with a US HQ and a growing team of 15, Allonic is building the hardware foundation for the next generation of intelligent machines.
  • Heywa Labs — Heywa Labs develops Generative UX (GenUX), an AI-driven interface layer that creates dynamic, adaptive user experiences beyond static text or links. Their flagship app, Heywa, delivers visual, tappable "stories" of cards for tasks like cooking, travel, fitness, and DIY, reconfiguring in real-time based on user interactions.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
bumpkins profile
Angel · 4 investments in Life Science startups

blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Canada, India

Investor stats

  • Total investments: 49
  • Round size: Seed $2.3M–$9.1M; Pre-Seed $500k–$2M; Series A $10M–$57M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Sorare — Global Fantasy Football. Collect limited edition digital collectibles, Manage your team and earn prizes!
  • Hoth Intelligence — Hoth Intelligence home page. Space age surgical technology brought down to earth.
  • Floating Point Group — Floating Point Group is a trading platform provider offering innovative, industry-leading trade execution and settlement
Show all investments...

Christopher Gibson
Angel · Salt Lake City, Utah, United States · 4 investments in Life Science startups

Christopher Gibson is based out of Salt Lake City, Utah, and is the Interim Executive Advisor, Co-Founder and Chairman of the Board of Directors of Recursion Pharmaceuticals. Christopher previously worked at Cure Hereditary Hemorrhagic Telangiectasia as a Member of the Board of Directors. Christopher Gibson attended the University of Utah.Christopher Gibson has been awarded the 2013 TEDMED Front Line Scholar.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series A, Seed, Series B
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 25
  • Round size: Seed $5.4M–$14M; Series A $12M–$55M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Zanskar — Zanskar Geothermal & Minerals uses custom AI tools and geoscience models to analyze vast amounts of data and pinpoint untapped geothermal hotspots.
  • Play Health — Delivering data & AI-driven (peri)menopause care software to improve outcomes today, developing precision medicine infrastructure for tomorrow.
  • Dunia Innovation — Catalysing the energy transition.
Show all investments...

Darian Shirazi
Angel · San Francisco, California, United States · 3 investments in Life Science startups, 8 in the past 12 months

Darian Shirazi is the Managing Partner of Gradient.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: United States, Germany, Canada

Investor stats

  • Total investments: 185
  • Round size: Seed $2M–$10M; Series A $6.3M–$30M; Series B $22M–$73M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • SolveAI
  • Rowspace — Specialized intelligence for investors. Compound your firm's edge. We're hiring!
  • Harmattan AI — Building the Future of Autonomous Warfare.
Show all investments...

Esther Dyson
Angel · New York, New York, United States · 3 investments in Life Science startups

Esther Dyson - Founder @ Way to Wellville

Show more...

Investment focus

  • Industry: Health Care, Software, Medical
  • Stage:Seed, Series A
  • Geography: United States, Canada, Russian Federation

Investor stats

  • Total investments: 72
  • Round size: Seed $270k–$4.3M; Series A $1.5M–$16M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • The Beans — The Beans offers a software application platform that creates personalized cash flow plans designed for its users. The Beans is Simplifying the path to financial balance through design and technology so that people can focus on what they love.
  • NextSense — Introducing NextSense Smartbuds: EEG-powered earbuds that go beyond sleep tracking. Backed by science, Smartbuds provide real-time insights to help you achieve deeper, more restorative sleep. Comfortable, intuitive, and easy to use, Smartbuds empower you to wake up your best self.
  • Openwater — OPENWATER - THE FUTURE OF NEURAL DIAGNOSTICS IN THE PALM OF YOUR HAND.
Show all investments...

Bradley Horowitz
Angel · Palo Alto, California, United States · 3 investments in Life Science startups

Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation. He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and GoogleNews.Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy.Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences.Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 132
  • Round size: Seed $150k–$18M; Series A $7.2M–$36M; Series B $19M–$120M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • Key AI — Unlock new networking and career opportunities with Key, the leading AI-powered professional networking platform. Build and manage communities, host and join exclusive events, and create meaningful connections to supercharge your growth all in one place.
  • Catena Labs — Catena is a product studio where we transform complex computing advancements into accessible, practical tools for users and developers. Leveraging AI and web3 technology our aim is to turn innovative ideas into real-world applications that are easy to use.
  • Odyssey — Odyssey is an AI lab pioneering general world models: causal, multimodal systems that learn to understand and simulate the world.
Show all investments...

Chris Gibson
Angel · Salt Lake City, Utah, United States · 3 investments in Life Science startups

Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Series A, Seed
  • Geography: United States, France, Switzerland

Investor stats

  • Total investments: 10
  • Round size: Seed $4.9M–$14M; Series A $6.3M–$55M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Amenities Health — Amenities is the healthcare industry's leading Digital Front Door and patient loyalty platform. We help healthcare providers to acquire new patients and upgrade them to members. Our all-in-one patient app works with most modern EMRs to: 1) register new users into a full EMR account in <30 seconds with full identity verification and noduplicates, 2) help those patients find care options and book appointments with simple, conversion-optimized workflows, 3) seamlessly integrates key patient portal and 3rd party functions (i.e., video visits, secure messaging, test results, and billing), and 4) upgrade patients to members with custom experiences and services offerings (i.e., for Medicare Advantage, concierge memberships, direct-to-employer, or direct primary care patients)
  • Cradle — Using robust prediction algorithms and AI design recommendations, Cradle assists biologists in rapidly designing better proteins. Cradle gives you complete ownership of the intellectual property while maintaining the privacy and security of your sequences and data.
  • Leash Biosciences — We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of protein to generate billions of data points, ideal for training advanced machine learning models.
Show all investments...

Ian Hogarth
Angel · London, England, United Kingdom · 3 investments in Life Science startups

Ian Hogarth is based out of London, England, and is the Chairman of Phasecraft. Ian previously worked at Songkick as a Chairman. Ian Hogarth attended the University of Cambridge.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, E-Commerce
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 56
  • Round size: Seed $1.5M–$7.9M; Pre-Seed $668k–$7.5M; Series A $11M–$28M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • Unitary — We detect harmful content with context-aware AI to keep brands and platforms safe online.
  • Cordless — Bridging the gap between voice and text
  • Fabric — Fabric is an AI-powered workspace and file manager for people and groups.Fabric is a self-organizing multiplayer workspace.
Show all investments...

Andrew Nutter
Angel · Paris, Ile-de-France, France · 3 investments in Life Science startups

Andrew Nutter is a Co-Founder at Gama. He attended Stanford University.

Show more...

Investment focus

  • Industry: Software, SaaS, FinTech
  • Stage:Seed, Pre-Seed, Series A
  • Geography: France, United Kingdom, United States

Investor stats

  • Total investments: 25
  • Round size: Seed $550k–$4.9M; Pre-Seed $809k–$3.4M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Yavin — Yavin provides modern point-of-sale solutions for European merchants. Yavin is a tool to receive payments, sell smarter, and grow the business.
  • Gama — Thanks to cheap, reliable and scalable solar sails, we are redefining deep space access.
  • EV Biotech — We design and optimise your precision fermentation strains and processes, tailored to your success.
Show all investments...

Albert Wenger
Angel · New York, New York, United States · 3 investments in Life Science startups

Albert Wenger is a managing partner at Union Square Ventures. Before joining USV, Albert was the president of del.icio.us through the company’s sale to Yahoo and an angel investor (Etsy, Tumblr). He previously founded or co-founded several companies, including a management consulting firm and an early hosted data analytics company. Albert graduatedfrom Harvard College in economics and computer science and holds a Ph.D. in Information Technology from MIT.

Show more...

Investment focus

  • Industry: Software, Internet, Analytics
  • Stage:Series A, Series B, Seed
  • Geography: United States, Germany, Switzerland

Investor stats

  • Total investments: 108
  • Round size: Seed $650k–$16M; Series A $1M–$40M; Series B $4.3M–$30M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • Brale — One regulated system for stablecoin issuance, custody, payments, and compliance. 75+ programs in production across 45 US jurisdictions. SOC 2 Type II. Book a demo.
  • Terra.do — Learn about climate change and start working on climate change solutions today with the Terra.do community.
  • Phlair — Carbon Atlantis is producing energy-efficient approach for ocean-based carbon dioxide removal.
Show all investments...

Erik Peterson
Angel · Chicago, Illinois, United States · 3 investments in Life Science startups

Erik Peterson is the Founder at DormTrader.

Show more...

Investment focus

  • Industry: Software, SaaS, Mobile
  • Stage:Seed, Equity Crowdfunding, Series A
  • Geography: United States, Canada, Algeria

Investor stats

  • Total investments: 60
  • Round size: Seed $150k–$4.5M; Series A $4M–$20M; Equity Crowdfunding $69k–$4.9M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Hideout — Hideout makes high-quality food that is available for delivery. Danielle Sobel established the company in Los Angeles, California.
  • Abalone Bio — Our Functional Antibody Selection Technology platform (FAST) taps into the potential of the body's biological activities, expanding the reach of antibody drugs.
  • Altay Therapeutics — Pioneering the first oral drug for FSHD and advancing cancer treatment solutions.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Mei Z.
Angel · San Francisco Bay Area, California, United States · 3 investments in Life Science startups

Mei is an early stage investor focused on AI. Mei studied at MIT and the MIT Media Lab

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Singapore

Investor stats

  • Total investments: 32
  • Round size: Seed $4M–$101M; Pre-Seed $1M–$11M; Series A $17M–$156M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • FlyMy.AI — Real-time AI cloud
  • Medra AI — Building robotics to accelerate scientific breakthroughs. At Medra, our mission is to automate repetitive wetlab tasks so scientists can more easily collect data and run the experiments needed to make groundbreaking scientific discoveries.
  • Periodic Labs — From bits to atoms.
Show all investments...

Kevin Mahaffey
Angel · San Francisco, California, United States · 3 investments in Life Science startups

Kevin Patrick Mahaffey is the Founder of Lookout and SNR. He is also the Executive Chairman of Stork Club and an Investor.

Show more...

Investment focus

  • Industry: Software, SaaS, Artificial Intelligence
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 151
  • Round size: Seed $1.3M–$8M; Pre-Seed $1.5M–$5.6M; Series A $5.3M–$30M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Mason America, Inc. — Mason is the device innovation platform for product leaders who dare to deliver the next innovation in their field.
  • Cara — Cara is a domain-specific AI platform purpose-built for insurance—a modular system that enables agencies, brokerages, and MGAs to automate servicing, accelerate sales, and scale operations with a 24/7 digital workforce.
  • Triangle Health — Triangle Health is a software company that uses artificial intelligence to analyze medical documents.
Show all investments...

Andrew Keys
Angel · 3 investments in Life Science startups

Andrew Keys is the Co-Founder and Managing Partner of Andrew Keys. He previously worked for ConsenSys as a Head of Global Business Development. Andrew Keys attended Loyola University Maryland.

Show more...

Investment focus

  • Industry: Software, Finance, Blockchain
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, India, Norway

Investor stats

  • Total investments: 14
  • Round size: Seed $1M–$34M; Pre-Seed $1.4M–$2.5M; Series A $14M–$15M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Stackr Labs — Micro-rollups to scale web3 applications
  • Zivoe Finance — Join Zivoe in disrupting predatory high-interest lending.
  • Ithaca Finance — Ithaca Finance a cross-chain derivatives trading and settlements protocol, is composed of an on-chain settlement layer with an innovative off-chain matching engine.
Show all investments...

Jeff Hammerbacher
Angel · 3 investments in Life Science startups

Jeff Hammerbacher - Partner & Co-Founder @ Techammer

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Biotechnology
  • Stage:Seed, Series A, Angel
  • Geography: United States, Germany

Investor stats

  • Total investments: 33
  • Round size: Seed $1M–$20M; Angel $330k–$330k; Series A $3M–$25M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Lamin — Open data platform for traceable multimodal AI. Query, trace, and govern data with a lineage-native lakehouse for files, tables, arrays, ontologies, and notes.
  • Ridge AI — Ridge AI makes it fast and easy for SaaS companies to prove value inside their product.
  • United Manufacturing Hub — The United Manufacturing Hub is an Open-Source Industrial IoT Infrastructure Platform enabling to easily connect, configure, manage, and maintain their factory.
Show all investments...

Stefano Bernardi
Angel · San Francisco, California, United States · 3 investments in Life Science startups

Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.

Show more...

Investment focus

  • Industry: Software, Blockchain, Biotechnology
  • Stage:Seed, Pre-Seed
  • Geography: Italy, United Kingdom, France

Investor stats

  • Total investments: 17
  • Round size: Seed $100k–$45M; Pre-Seed $874k–$2.2M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Freatic — Building the monetization layer for your alpha
  • Niulinx — Niulinx specializes in providing autonomous driving technology solutions based on artificial intelligence, connectivity, and data analytics.
  • Automated Architecture — A global ecosystem of automated micro-factories, to deliver sustainable, affordable and beautiful architecture to millions of people.
Show all investments...

Zach Weinberg
Angel · New York, New York, United States · 2 investments in Life Science startups

Before co-founding Flatiron, Zach was Co-Founder, President and COO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Zach co-foundedEatNow.com which was privately acquired. An active angel investor, Zach has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough.com, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Zach studied economics and entrepreneurship at The Wharton School at the University of Pennsylvania.

Show more...

Investment focus

  • Industry: Software, Health Care, Medical
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 72
  • Round size: Seed $1.4M–$7.6M; Pre-Seed $1.5M–$2.3M; Series A $3M–$30M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Scoop — Thrive in a hybrid work environment with Scoop's solutions for Workplace Safety, Workplace Utilization, Team Coordination, Desk Management, and Commute.
  • Crosby — The AI Law Firm Built for Execution. Lawyer-assisted AI to review MSAs, DPAs and NDAs in under an hour.
  • Overwatch Research — Generate accurate in vivo study data as a part of your efficient, connected R&D.
Show all investments...

David Helgason
Angel · Copenhagen, Hovedstaden, Denmark · 2 investments in Life Science startups

David is a technologist, the founder of Unity Technologies, non-exec director to others, and a restless entrepreneur with a passion for creating feedback loops between innovation and teams and products, applying new and old business models to changing industries, and pushing people to do the very best they can do.David's background is inprogramming, an assortment of university dabbling, creating companies, and helping entrepreneurs. He served as CEO of Unity Technologies since co-founding it in 2003 and until October 2014, with an unflinching vision to democratize game development, and to develop technology and business models for the next phase of the games industry. David Helgason attended the University of Copenhagen.

Show more...

Investment focus

  • Industry: Software, Gaming, Artificial Intelligence
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Denmark, Finland

Investor stats

  • Total investments: 79
  • Round size: Seed $1.1M–$8M; Pre-Seed $242k–$2.4M; Series A $4.3M–$30M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • ScyAI — Risk intelligence that thinks with you.
  • Noah — API-first stablecoin payments, enterprise-grade compliance and real-time settlements, powered by stablecoin technology.
  • Flow Engineering — Requirements management, made collaborative
Show all investments...

CJ Reim
Angel · San Francisco, California, United States · 2 investments in Life Science startups

CJ Reim is a co-founder of Amity Ventures and an active investor in Avochato, Carta, Ouster, Talkdesk, and more than 15 other growing technology businesses. CJ is currently focused on investments in software, fintech, and consumer sectors, and represents Amity on the boards of Avochato and MaintainX.Prior to Amity, CJ was a Vice President on theinvestment team at Highland Capital Partners, where he focused on technology investments across all stages of company growth. He also led the Summer@Highland entrepreneurship program which, over its nine-year history, has mentored 50 student-led startups from inception. CJ is originally from Minnesota and holds a B.S. in Management with concentrations in Finance and Information Systems from Boston College. Outside of Amity, CJ enjoys CrossFit, freediving, and downhill skiing.

Show more...

Investment focus

  • Industry: SaaS, Robotics, E-Commerce
  • Stage:Series A, Seed, Series D
  • Geography: United States

Investor stats

  • Total investments: 18
  • Round size: Seed $3.7M–$9.7M; Series A $5M–$27M; Series D $80M–$150M
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
  • Burrow — Meet Burrow. We make clever, uncompromising furniture and other nice things fit for modern life at home. From our comfortable, customizable sofas, sectionals, loveseats, and armchairs to our fashionable, functional rugs and tables, and five unique collections of decorative pillows and throw blankets, Burrow is the perfect place to start when shopping for your home.
  • Arkive — Arkive is a web3 museum of real world items, curated by a community of passionate hobbyists, collectors, artists, designers, and creators.
Show all investments...

Katie Haun
Angel · San Francisco, California, United States · 2 investments in Life Science startups

Katie is the founder and CEO of Haun Ventures, a Silicon Valley venture fund that manages billions in investments across frontier technologies including blockchain and digital assets. The firm’s institutional investors are major sovereign wealth funds, endowments, foundations, financial institutions, and other global organizations.She has servedas a board member of several high-growth technology companies. As Coinbase’s first independent director, she was an early architect of company’s global regulatory strategy, serving through its direct listing and subsequent growth as a publicly traded company. During her tenure from 2017 to 2024, she held several positions including Chair of the Nomination and Governance Committee, Chair of the Audit and Risk Committee, and member of the Compensation Committee.Katie joined Andreessen Horowitz as a General Partner in 2018. There, she co-led their crypto franchise, building a team and investing out of three successive funds with billions under management, generating significant realized returns for institutional investors.Before her venture career, Katie spent over a decade as a federal prosecutor with the U.S. Department of Justice. She secured successful jury verdicts in every case she tried and led high-profile prosecutions related to the Silk Road task force, the 2012 Hells Angels murder trial, and the Nuestra Familia prison gang RICO takedown. She also led cyber, corporate, and violent crime investigations in partnership with the FBI, Homeland Security, SEC, and Treasury. At DOJ headquarters, she held senior leadership positions in the National Security Division and later the Attorney General’s office where her portfolio covered antitrust, tax, and national security matters. Katie represented DOJ on both CFIUS and the FBI’s Undercover Review Committee, that approved significant undercover operations.Katie has been profiled by Bloomberg, Fortune, The New York Times, and CNBC and was named one of Bloomberg BusinessWeek’s 50 Most Influential in 2022.

Show more...

Investment focus

  • Industry: Blockchain, Financial Services, FinTech
  • Stage:Seed, Series A
  • Geography: United States, United Kingdom

Investor stats

  • Total investments: 22
  • Round size: Seed $4.5M–$200M; Series A $15M–$55M
  • Lead/follow: 32% lead, 68% follow

Portfolio highlights

  • dub — The first Copy-Trading platform for stocks. Copy anyone's investments. For free. Regulated Broker-Dealer member FINRA and SIPC & FDIC insured.
  • Primer — Primer is the world's first community built for curious and ambitious kids to find and explore their interests together.
  • Coinbase Token Manager — LiquiFi helps crypto companies automate token vesting, issue token grants in compliance, and manage their token cap table.
Show all investments...

Carsten Maschmeyer
Angel · Hanover, Niedersachsen, Germany · 2 investments in Life Science startups

Carsten Maschmeyer is a successful entrepreneur, consultant and financial investor. He was born on May 8, 1959 in Bremen and grew up in Hildesheim. After his graduation in 1978 Maschmeyer completed military service before he began to study medicine in Hannover. To finance his studies, he worked part-time in sales of investment advice to it in 1982completely dedicated financial advice. More about Carsten Masch Meyers consultant. In 1988 Carsten Maschmeyer to AWD financial group, which was successfully launched on the stock market in 2000 and rise to the MDAX and expanded in 11 countries. Was sold in 2007 Carsten Maschmeyer all his shares in the company at the insurance group Swiss Life, who renamed the AWD in AWD Holding. Maschmeyer has today different occupational focuses, inter alia, as entrepreneur, investor and consultant. His experience Carsten Maschmeyer a sought-after speaker on the subject of success. Motivated by the desire expressed by many listeners to learn more about his secret of success, Carsten Maschmeyer published in the spring of 2012 his book "Self Made - performance live richly". In it he describes the basis of his own exciting path and the celebrities strategies for professional, financial and personal success.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Angel, Series A
  • Geography: Germany, Austria, Switzerland

Investor stats

  • Total investments: 83
  • Round size: Seed $106k–$4.2M; Angel $89k–$548k; Series A $1.6M–$24M
  • Lead/follow: 28% lead, 72% follow

Portfolio highlights

  • Zeedz — Gaming for a green future. Zeedz is a monster collectible game that targets real-world climate change. Discover a world of plantified magic, made in Berlin.
  • Finperks — finperks is a prepaid infrastructure API for banks, neobanks, HR platforms, etc. in Europe. Access 1000+ brands across 30+ countries. Simplify contracts, settlements, and integrations to scale your prepaid, cashback, and employee benefits solutions.
  • admark.ai — admark.ai combines cutting-edge AI language models with social media data
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Sujay Jaswa
Angel · San Francisco, California, United States · 2 investments in Life Science startups

Sujay Jaswa is founder and managing partner at WndrCo, a holding company that invests in and acquires consumer technology businesses. He serves as Chairman of Aura, Twingate, VPN Super, and is a Director of The Infatuation. Board member of Vy Global Growth (Nasdaq: VYGG). Advisor at Seven1 Sports & Entertainment Agency. He is also a lecturerat the Stanford Graduate School of Business. He formerly served as business founder, vice president of business, and CFO of Dropbox from 2010 to 2015. At Dropbox, Sujay created and led the global business and finance organization. He has a Bachelor’s degree in Economics from Princeton University and an MBA from Harvard Business School.

Show more...

Investment focus

  • Industry: Software, Apps, FinTech
  • Stage:Seed, Series B, Series A
  • Geography: United States, Spain, Germany

Investor stats

  • Total investments: 30
  • Round size: Seed $1.8M–$10M; Series A $11M–$200M; Series B $15M–$85M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • HUBUC — A single API-platform that allows any business to embed financial services capabilities into their products. 
e.g Uber can issue branded credit cards for all Uber drivers and Walmart provides customers a simple way to better manage and control their everyday finances, with no regulatory burden or compliance requirements in a few weeks.
  • point.me — Search and book award flights and maximize the value of your points. Travel on points for less with point.me's flight award search tool.
  • PlayerZero — PlayerZero builds a production world model so SRE, QA, and support resolve incidents, prevent defects, and close tickets faster. Trusted by Verizon & Zuora.
Show all investments...

Lars Fjeldsoe-Nielsen
Angel · London, England, United Kingdom · 2 investments in Life Science startups

Lars Fjeldsoe-Nielsen grew up across Africa, from Angola and Guinea-Bissau to Tanzania and Libya, after his family fled the Angolan Civil War as refugees. Those early experiences instilled in him a belief that education, technology, and social innovation can transform lives and continue to anchor his career and philanthropic activities to this day.Today, Lars is a General Partner at Owl Ventures ($2.2 billion AUM), the world’s leading venture capital firm focused exclusively on education technology. He leads Owl’s expansion across Europe, Africa, and global markets, backing founders who harness AI and breakthrough technologies to make learning more accessible and impactful.Before joining Owl, Lars co-founded 2xN, an early-stage fund at the frontier of deeptech and quantum innovation, with standout investments including Quantinuum (valued above $10 billion), Oxford Ionics (acquired by IonQ in a $1 billion deal), QSimulate, and Sparrow Quantum. Prior to that, he was a General Partner at Balderton Capital in London during which time the firm led the Seed and Series A rounds in Revolut. His investments also span education (Labster, uLesson, StudySmarter, Kukua), mobility (Yassir, Voi, Monta, NoTraffic), and mobile and frontier tech (Hiya, Monarch Money, Rahko, Pocket, Colossal, Celus, Octant Bio, Vivino, OpenSea, Blue Bottle Coffee).Lars previously spent a decade in Silicon Valley, shaping some of tech’s most iconic growth stories. At Uber, he joined when it operated in fewer than 20 cities and, as Vice President, forged global alliances with Verizon and América Móvil that fueled its international expansion. Before Uber, as Head of Mobile at Dropbox, he was among the first 25 employees and helped the company reach its first 100 million users through partnerships with Samsung and other OEMs.Despite his career in technology and venture capital, Africa has never left Lars’s journey. After his father’s passing, he returned to Angola to trace his family’s history, discovering that his sister had died of malaria as a child. That revelation transformed a personal loss into a mission. A technologist turned humanitarian innovator, Lars filed a patent for genetically modified mosquitoes that light up when carrying malaria and began funding malaria-research projects in Angola through partnerships with global nonprofits. In 2024, he climbed Mount Kilimanjaro to raise funds for malaria research, following earlier campaigns such as climbing the Matterhorn and crossing the Sahara by motorbike.A Danish-Portuguese national who served with the Royal Danish Guards, Lars holds an MBA from London Business School, where he was a member of the Board of Governors and Chairman of the Endowment Fund, an MSc from Oxford University (Keble College), and a BSc from King’s College London. Across every chapter, from refugee to technologist to investor, his purpose endures: advancing education, health, and innovation as catalysts for social change.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Denmark

Investor stats

  • Total investments: 98
  • Round size: Seed $1.8M–$10M; Series A $6.4M–$48M; Series B $15M–$125M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Blue — An Operating System for your Personal Health. Join the waitlist here.
  • UrbanKisaan — UrbanKisaan builds vertical farms in India and sells the produce directly to consumers via subscription based app. The farms create a positive change at every step from seed to store ensuring quality and traceability. They grow fresh veggies locally produced which are grown without using soil using 95% less water. It aims to create a sustainablefuture for farming and feed the world in a way that is good for both people and the planet.It was founded in 2017 and is headquartered in Hyderabad, Andhra Pradesh, India.
  • Colossal Biosciences — The science of genetics. The business of discovery.
Show all investments...

Jon Oringer
Angel · New York, New York, United States · 2 investments in Life Science startups

Jon Oringer is the founder and chairman of Shutterstock.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, France, United Kingdom

Investor stats

  • Total investments: 115
  • Round size: Seed $500k–$5.5M; Pre-Seed $175k–$2.5M; Series A $4M–$56M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • SLUSHY — SLUSHY is a secure mobile web based platform for content creators to find, grow, & monetize their audiences. A creator first, tech-driven tool, designed with key discoverability features and audience insights. In a market where existing solutions (OnlyFans, Patreon) fall short of their creators' demands, SLUSHY provides an alternativesolution for professional content creators that prioritizes their monetization, support and management needs. SLUSHY incorporates a powerful legal framework, with robust compliance tools including simplified consent, ID verification, and content moderation. The new home of unrestricted content, SLUSHY is here.
  • Unsloth AI — Unsloth is an open-source, no-code web UI for training, running and exporting open models in one unified local interface.
  • OneImaging — OneImaging makes life-saving diagnostics affordable, accessible, and personal. We connect employers, health plans, and members to a trusted national network of imaging centers, delivering faster answers with transparent pricing and premium care across MRIs, CT scans, ultrasounds, mammograms, X-rays and more. We serve organizations looking to control medical spend and individuals who need reliable results without delays. Every scan booked through OneImaging is proof that healthcare can be simpler, cheaper, and kinder.
Show all investments...

Ed Parkinson
Angel · 2 investments in Life Science startups

Ed Parkinson

Show more...

Investment focus

  • Industry: Health Care, Life Science, Biotechnology
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Round size: Seed $1.9M–$3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Antiverse — Designing biologics for 100 challenging targets
Show all investments...

Elad Gil
Angel · San Francisco, California, United States · 2 investments in Life Science startups

Elad Gil is the Co-Founder of Color Genomics. He previously worked at Twitter as a Vice President. Elad Gil attended the Massachusetts Institute of Technology.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 259
  • Round size: Seed $2M–$17M; Series A $9.5M–$50M; Series B $27M–$117M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • NavigateAI — An AI copilot for every person in the field. NavigateAI upskills and coaches your team, runs real-time quality control, manages the project in the background, and provides expert knowledge, instantly.
  • Harvey — Harvey is an artificial intelligence technology service provider.
  • Socket — Socket fights vulnerabilities and provides visibility, defense-in-depth, and proactive supply chain protection for JavaScript, Python, and Go dependencies.
Show all investments...

Robert Kopple
Angel · Los Angeles, California, United States · 2 investments in Life Science startups

Robert C. Kopple is based out of Vancouver, Ontario, and is the Partner of Kopple, Klinger & Elbaz. Robert previously worked at Gelum Resources as a Board of Directors. Robert C. Kopple attended New York University.

Show more...

Investment focus

  • Industry: FinTech, Finance, Life Science
  • Stage:Convertible Note, Venture - Series Unknown
  • Geography: United States, United Kingdom

Investor stats

  • Total investments: 3
  • Round size: Venture - Series Unknown $3.3M–$4.8M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Tradier — Tradier is a financial services cloud provider that offers a groundbreaking solution to serve platform providers, developers and investors. The Tradier solution features an innovative set of fully hosted APIs, modules, and "out of the box" tools that are leveraged by a growing list of providers.
  • ILC Therapeutics — ILC Therapeutics Ltd is an early-stage biotechnology company focused on modulating the Innate Immune System through the development of novel peptide therapeutics for the treatment of Covid-19, Cancer, Atopic Dermatitis, and Psoriasis.
Show all investments...

James Hong
Angel · San Francisco, California, United States · 2 investments in Life Science startups

James Hong

Show more...

Investment focus

  • Industry: E-Commerce, Mobile, Internet
  • Stage:Seed, Series A, Angel
  • Geography: United States

Investor stats

  • Total investments: 29
  • Round size: Seed $100k–$3.7M; Angel $975k–$3M; Series A $1M–$25M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
  • Deep Infra — Deep Infra offers cost-effective, scalable, easy-to-deploy, and production-ready machine-learning models and infrastructures for deep-learning models.
  • Alchemy — Whether you're a beginner, working on a side project, or one of the largest teams in the blockchain space, Alchemy makes Ethereum development easy with enhanced APIs, node infrastructure, and developer tooling. Get started for free!
Show all investments...

Avichal Garg
Angel · Stanford, California, United States · 2 investments in Life Science startups

Avichal is Managing Partner at Electric Capital. He is a serial entrepreneur and technology executive. Avichal sold two companies and was most recently Director of Product at Facebook, which acquired his company Spool in 2012. He previously worked at Google on search ranking and ads ranking, is part-time at YCombinator, and an active angelinvestor.Avichal's firm, Electric Capital, focuses on cryptocurrencies that are rooted in technological utility. Electric performs deep technological diligence, such as compiling code, profiling nodes, and analyzing blockchains with in-house software. The founders of Electric have started and sold five companies, have been investing in cryptocurrencies since 2013, and are investors in Anchor, Bitwise, Chia, Coda, dYdX, Dfinity, Oasis, Thunder and many other crypto projects.

Show more...

Investment focus

  • Industry: Software, Blockchain, Internet
  • Stage:Seed, Series A
  • Geography: United States, Canada, Mexico

Investor stats

  • Total investments: 85
  • Lead/follow: no public data

Portfolio highlights

  • Key — Unlock new networking and career opportunities with Key, the leading AI-powered professional networking platform. Build and manage communities, host and join exclusive events, and create meaningful connections to supercharge your growth all in one place.
  • Matic — The world's most advanced floor cleaner. Your home's best helper.
  • Bluenote Health — Accelerate innovation with AI built for and trusted by leading life sciences companies.
Show all investments...

Jan Hammer
Angel · London, England, United Kingdom · 2 investments in Life Science startups

Jan Hammer is the partner at Index and the Board observer of Harmonic. Jan attended Oxford University.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Czech Republic

Investor stats

  • Total investments: 64
  • Lead/follow: no public data

Portfolio highlights

  • Sofía — Improving the way millions of people take care of their health
  • Transak — Transak offers a simple integration to allow your users to buy more than 100+ cryptocurrencies with credit/debit cards, or bank transfers in more than 120+ countries.
  • Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.
Show all investments...

Michael Novogratz
Angel · New York, New York, United States · 2 investments in Life Science startups

Michael E. Novogratz is based out of New York, New York, and is the Founder and CEO of Galaxy Digital. Michael previously served at Partner and President of Fortress Investment Group. Michael E. Novogratz attended Princeton University.

Show more...

Investment focus

  • Industry: Blockchain, FinTech, Cryptocurrency
  • Stage:Seed, Series A, Series B
  • Geography: United States, India, Germany

Investor stats

  • Total investments: 32
  • Round size: Seed $1.1M–$8.5M; Series A $11M–$38M; Series B $15M–$150M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • Curative — Get on-the-go COVID-19 testing and other essential health services, wherever you are.
  • Mansa — Built by Black creators with a passion for making culture-positive content, Mansa is the only place to stream the best in Global Black stories
  • Galaxy Digital — Galaxy is a digital asset and blockchain leader helping institutions, startups, and individuals shape a changing economy.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Nicholas Edwards
Angel · Oxford, Oxfordshire, United Kingdom · 2 investments in Life Science startups

Nick serves as the Chairman of Prescient’s Board of Directors. He holds a degree in physiological sciences from The Queen’s College, University of Oxford, and completed his training in clinical medicine (BM, BCh) at Green College (now Green Templeton College), University of Oxford. Nick practiced in the areas of cardiology and general surgerybefore joining Andersen Consulting (now known as Accenture), eventually becoming the global leader of Accenture’s pharmaceutical R&D business during his 18-year tenure. In 2005, he founded Kinapse to provide consulting and outsourcing services to the pharmaceutical industry. Nick served as Kinapse’s Chairman until the company was sold to HgCapital in early 2016.

Show more...

Investment focus

  • Industry: Medical, Health Care, Life Science
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Show all investments...

Annie Vereecken
Angel · 2 investments in Life Science startups

Annie Vereecken

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Hospital
  • Stage:Seed, Series A
  • Geography: Belgium

Investor stats

  • Total investments: 6
  • Lead/follow: no public data

Portfolio highlights

  • Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
  • Sensolus — Introducing our smart, industrial-grade tracking solution. With battery life of up to ten years, and no additional infrastructure needed.
  • Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Show all investments...

Luc Vauterin
Angel · 2 investments in Life Science startups

Luc Vauterin - Board Member @ ONTOFORCE

Show more...

Investment focus

  • Industry: Life Science, Data Integration, Data Visualization
  • Stage:Seed, Series A
  • Geography: Belgium

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • ONTOFORCE — ONTOFORCE creates and implements pioneering semantic search technology for information management. Our user-friendly data search platform DISQOVER builds uniquely intelligent links between heterogeneous data sources, allowing everybody to become a data scientist.
Show all investments...

Sauli Törmälä
Angel · Helsinki, Southern Finland, Finland · 2 investments in Life Science startups

Sauli Törmälä is the Board Member, CFO at Promilless Oy. He attended University of Oulu.

Show more...

Investment focus

  • Industry: Life Science, Biotechnology
  • Stage:Seed
  • Geography: Finland

Investor stats

  • Total investments: 2
  • Round size: Seed $584k–$1.3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
Show all investments...

Pierre Drion
Angel · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 2 investments in Life Science startups

Pierre Drion - CEO @ Petercam

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Series A, Series B
  • Geography: Belgium

Investor stats

  • Total investments: 5
  • Lead/follow: no public data

Portfolio highlights

  • A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
  • Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
  • Santero Therapeutics — This is the homepage of the website
Show all investments...

Holger Hübner
Angel · Hamburg, Hamburg, Germany · 2 investments in Life Science startups

Holger Hübner

Show more...

Investment focus

  • Industry: B2B, SaaS, Audio
  • Stage:Seed, Pre-Seed
  • Geography: Germany

Investor stats

  • Total investments: 5
  • Round size: Seed $560k–$987k; Pre-Seed $177k–$329k
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • musicube — MassiveMusic is a global music and sound partner specializing in sonic branding, sound strategy, music innovation & licensing.
  • RetroBrain R&D GmbH — Memore gamifies proven dementia therapies into a gesture controlled medical video game. It incorporates and gamifies proven therapies, delaying the effects of dementia and mild cognitive impairment, enabling elderly people without prior gaming experience to utilize the gaming suite easily.Memore works both therapeutically and preventatively withnursing rehabilitation. It was founded in 2014 and is based in Hamburg, Germany.
  • HorseAnalytics — HorseAnalytics empowers horse enthusiasts to monitor and improve health and training of horses by applying reliable technologies from health and sports supervision and combining constant and real-time scientific analytics.
Show all investments...

Peter Harris
Angel · 2 investments in Life Science startups

Peter Harris

Show more...

Investment focus

  • Industry: Life Science, Biotechnology, Health Diagnostics
  • Stage:Seed
  • Geography: United States

Investor stats

  • Total investments: 2
  • Round size: Seed $2.4M–$5M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • CND Life Sciences — CND advances neurodiagnostics through skin biopsy testing, including the Syn-One Test, for neurodegenerative diseases.
Show all investments...

Leena Niemist&ouml;
Angel · Helsinki, Southern Finland, Finland · 2 investments in Life Science startups

Leena Niemistö

Show more...

Investment focus

  • Industry: Health Care, Software, E-Commerce
  • Stage:Seed, Pre-Seed
  • Geography: Finland, United States

Investor stats

  • Total investments: 19
  • Round size: Seed $480k–$3.2M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • Vapaus — A circular economy startup Vapaus provides sustainable mobility solutions – Employee benefit bicycles and shared electric vehicles as a ready-to-use serviceWith its services, Vapaus supports customers’ to create and strengthen a better experience of the work community, to save on the costs of commuting and business travels, and to move towardssmarter and more environmentally friendly modes of transport, both at work and in employees’ leisure time.Every kilometer traveled by the Vapaus mobility solution removes carbon dioxide from the air, helping not only the environment but also customers on their way to carbon neutrality. The mission of Vapaus is to be a global leader when it comes to sustainable Corporate Mobility.
  • ADESANTE — SurgeryVision is a Virtual Reality solution for Surgeons. Product is intended to be used for planning surgical procedures.
  • Maire — Maire - AI co-pilot for industry leading B2C E-commerce brands. From Industry Trends to Market Research and Search Intent Analysis
Show all investments...

Thor Bjorgolfsson
Angel · London, England, United Kingdom · 2 investments in Life Science startups

Thor Bjorgolfsson - Entrepreneur, Businessman and Adventure Capitalist Thor Bjorgolfsson, Iceland’s first and only current billionaire, is an investor and business innovator who is not afraid of risk. He has been an entrepreneur since childhood, making his first deal at the age of 10, when he purchased a stack of vintage Marvel comics withborrowed money.In 2004, he founded Novator Partners, an alternative investment firm. He has strategically developed the company to allow it to maintain maximum flexibility as well as to facilitate investments in both strategic (buy and hold) and financial (buy and exit) opportunities.With Novator, Thor leverages private equity as well as macro investments and manages assets across a variety of sectors and geographic locations. He is an active investor in emerging economies including Central and Eastern Europe as well as Latin America.Novator Partners has been a major player in telecom businesses. Thor is a stakeholder in a Polish telecom company called Play, which went public in 2017. In addition, he holds shares in WOM, a Chilean telecommunications firm.Bjorgolfsson’s first fortune was made in post-soviet Russia. At a time when others perceived Russia to be tumultuous, he saw an underserved market that presented an exciting opportunity to invest in great ideas and businesses. He co-founded and developed Bravo Brewery, which produced beer and alcopops. Bravo became one of Russia’s premier brewing companies, particularly through its popular Botchkarov beer brand. Thor sold the business in 2002 to Heineken for $100 million.With the sale of Bravo, he was able to diversify his holdings by reinvesting in new ventures, focusing on telecommunications, pharmaceuticals, and banks. In a few years, he was able to turn that $100 million into a net worth of over $2.1 billion.A year after being featured on the 2007 cover of Forbes Magazine, Iceland went nearly bankrupt overnight and Thor found himself at the epicenter of the financial crisis. As a major shareholder in Landsbanki with personal guarantees of 350m euro, he refused to declare bankruptcy and eventually succeeded in paying off all of it. He then went on to invest in new businesses, re-establishing himself and being featured on the Forbes list of billionaires once again.During this time of rejuvenation, he wrote Billions to Bust and Back: How I Made, Lost and Rebuilt a Fortune, And What I Learned on the Way (2014). In the book, he shares his perspective of what it was like to be at the center of the storm and how he made it back to financial success. He proposes that the greatest strength an entrepreneur can possess is a positive attitude.The 52-year-old Thor was educated in the United States where he earned a Bachelor of Science degree from New York University. In 2005, he was honored as a Young Global Leader by the World Economic Forum. In spite of his intense schedule, Thor enjoys sharing his experience and business insight, making him a sought-after speaker. A multilingual Icelandic citizen, Thor spends most of his time in London, living with his wife and three children. Thor's personal passion is his collection of six motorcycles, which he rides whenever time permits.

Show more...

Investment focus

  • Industry: Big Data, TV, TV Production
  • Stage:Seed, Series A, Series C
  • Geography: United Kingdom, Germany

Investor stats

  • Total investments: 6
  • Lead/follow: no public data

Portfolio highlights

  • Olvin — Olvin helps reactive real-world businesses get ahead of the curve and become proactive through the use of its AI powered, predictive analytics platform. Harnessing billions of real world data points, from events and precise location, through to weather and points of interest, Olvin's advanced neural network identifies patterns. Through theuse of both probabilistic and deterministic scoring, Olvin's AI provides actionable insights to brands, retailers and businesses to give them an unparalleled opportunity to delight their customers, identify opportunities and get ahead of potential threats.
  • DNEG — We are DNEG, one of the world's leading visual effects and animation studios for feature film and television, honoured with the Academy Award six times
  • AtaiBeckley — We are a clinical-stage biopharmaceutical company developing new mental health treatments to transform patient outcomes.
Show all investments...

Patrick Collison
Angel · San Francisco, California, United States · 2 investments in Life Science startups, 16 in the past 12 months

Patrick Collison is a CEO of Stripe.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Series A, Seed, Series C
  • Geography: United States, United Kingdom, Ireland

Investor stats

  • Total investments: 72
  • Round size: Seed $2.7M–$13M; Series A $10M–$105M; Series C $20M–$170M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Centivax — Centivax is a healthcare-based agency that provides biotechnology, pharmaceutical, medical device manufacturing, and therapeutic services.
  • The Interaction Company of California — The proactive AI assistant in your iMessage, WhatsApp, and more. Texts like a human, really knows you, and integrates with your life in dozens of ways.
  • SendCutSend — SendCutSend is an online custom manufacturing service specializing in rapid, high-precision sheet metal fabrication and CNC machining. Customers simply upload their digital design files to get professional-grade parts manufactured and shipped to their door, with turnaround times as fast as 24 hours.
Show all investments...

Life Science Angel investor funding at a glance

Stats across 524 deals from 727 investors.

727
investors
in Life Science startups
524
deals
in Life Science startups
$5M
median round
in Life Science startups
9%
lead investors
lead at least one round
37%
Seed
most common funding stage

Access all 727 angel investors in Life Science startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science Angel Investors investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 727 angel investors investing in Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists